Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bydureon1件: Exenatide1件: Exenatide (BYDUREON BCISE) 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 6, 17 💬
2Bydureon 2 MG powder and solvent FOR prolonged-release suspension1件: Exenatide1件: Exenatide (BYDUREON BCISE) 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
3Exenatide
(BYDUREON BCISE)		1件: Exenatide1件: Exenatide (BYDUREON BCISE) 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 17, 78, 193, 233 💬
4Exenatide 10 micrograms
(BYDUREON BCISE)		1件: Exenatide1件: Exenatide (BYDUREON BCISE) 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
5Exenatide 5 micrograms
(BYDUREON BCISE)		1件: Exenatide1件: Exenatide (BYDUREON BCISE) 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
6GLP1-RA (exenatide) administration
(BYDUREON BCISE)		----1件: 78 💬